Brokerages Set C4 Therapeutics, Inc. (NASDAQ:CCCC) Target Price at $11.86
C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Rating) has been given a consensus recommendation of “Hold” by the seven analysts that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. The […]